Peter M. Hecht - Jan 3, 2022 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Chief Executive Officer, Director
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Stock symbol
CYCN
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/24/2022, 10:38 AM
Previous filing
Jun 7, 2021
Next filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCN Employee Stock Option (Right to Buy) Award $0 +53K $0.00 53K Jan 3, 2022 Common Stock 53K $1.78 Direct F1
transaction CYCN Employee Stock Option (Right to Buy) Award $0 +430K $0.00 430K Jan 20, 2022 Common Stock 430K $1.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to 8.33333% of the shares of Common Stock on each monthly anniversary of January 3, 2022.
F2 The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 20, 2022.